It’s Time to Think Beyond National Pharmacare

 Make the evidence on drug safety and effectiveness public Recently federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the wake of this, there is new optimism that pharmacare, publicly funded and universally available to Canadians, might

Is Waiting Longer for New Prescription Drug Approvals Necessarily a Bad Thing?

 Why Canada’s ‘slow and low’ approach to new pharmaceuticals may be the prudent approach. The newest report from Canada’s brand name drug makers on access to new drugs has one key message: compared to other countries, Canada goes slow and low.  New drugs are slower to be covered by our

Time for Improved Transparency and Openness in Pharmaceutical Drug Regulation

 Prescription pharmaceuticals have saved and improved many lives, but they can also be deadly. How can we make sure Canadians get the prescription drugs they need without causing unnecessary harm? The federal government plays a vital role in pharmaceutical drug regulation. We have many reasons to be proud of the